相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis
Eiko Sakai et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients
Maurizio Zangari et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function
S. Vallet et al.
LEUKEMIA (2011)
Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in Bone
Xin Li et al.
STEM CELLS (2011)
Mesenchymal Stem Cells as Therapeutics
Biju Parekkadan et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 12 (2010)
PEDF regulates osteoclasts via osteoprotegerin and RANKL
Toru Akiyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Advances in the understanding of myeloma bone disease and tumour growth
Shmuel Yaccoby
BRITISH JOURNAL OF HAEMATOLOGY (2010)
The Pathophysiological Role of PEDF in Bone Diseases
M. L. Broadhead et al.
CURRENT MOLECULAR MEDICINE (2010)
Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation
Ignazio Barbagallo et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2010)
Cell-Based Immunotherapy With Mesenchymal Stem Cells Cures Bisphosphonate-Related Osteonecrosis of the Jaw-like Disease in Mice
Takashi Kikuiri et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Consequences of Daily Administered Parathyroid Hormone on Myeloma Growth, Bone Disease, and Molecular Profiling of Whole Myelomatous Bone
Angela Pennisi et al.
PLOS ONE (2010)
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease
Sonia Vallet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo
Angela Pennisi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth
Angela Pennisi et al.
BLOOD (2009)
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
Twyla B. Bartel et al.
BLOOD (2009)
Sleuthing the Source of Regeneration by MSCs
Mark Pittenger
CELL STEM CELL (2009)
Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6
Ryang Hwa Lee et al.
CELL STEM CELL (2009)
Mesenchymal Stem Cell Homing: The Devil Is in the Details
Jeffrey M. Karp et al.
CELL STEM CELL (2009)
Restoration of Bone Mass and Strength in Glucocorticoid-Treated Mice by Systemic Transplantation of CXCR4 and Cbfa-1 Co-Expressing Mesenchymal Stem Cells
Chun-Yang Lien et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors
M. Garayoa et al.
LEUKEMIA (2009)
Repair of Tissues by Adult Stem/Progenitor Cells (MSCs): Controversies, Myths, and Changing Paradigms
Darwin J. Prockop
MOLECULAR THERAPY (2009)
Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging
Shannon Kidd et al.
STEM CELLS (2009)
Autologous and Allogeneic Marrow Stromal Cells Are Safe and Effective for the Treatment of Acute Kidney Injury
Florian Toegel et al.
STEM CELLS AND DEVELOPMENT (2009)
Role of decorin in the antimyeloma effects of osteoblasts
Xin Li et al.
BLOOD (2008)
Immunosuppression by mesenchymal stromal cells: From culture to clinic
Ben J. Jones et al.
EXPERIMENTAL HEMATOLOGY (2008)
Lymph node mapping in the mouse
Maria I. Harrell et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance
Zhaokang Cheng et al.
MOLECULAR THERAPY (2008)
Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone
Robert Sackstein et al.
NATURE MEDICINE (2008)
Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses
Hirokazu Ohtaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells
Biju Parekkadan et al.
STEM CELLS (2008)
Skeletal Imaging and Management of Bone Disease
G. D. Roodman
Hematology-American Society of Hematology Education Program (2008)
Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury
Florian Toegel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Mesenchymal stem cells in health and disease
Antonio Uccelli et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies
Constantine S. Mitsiades et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of αvβ3 and αvβ5
Julie C. Crockett et al.
ENDOCRINOLOGY (2007)
Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines
Xin Li et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice
Mingxia Shi et al.
HAEMATOLOGICA (2007)
Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions
Darwin J. Prockop et al.
BLOOD (2007)
Magnetic resonance imaging in multiple myeloma: Diagnostic and clinical implications
Ronald Walker et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo
Shmuel Yaccoby et al.
BLOOD (2007)
Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice
Ryang Hwa Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells
WK Si et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival
Y Ge et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation
N Giuliani et al.
BLOOD (2005)
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
E Zappia et al.
BLOOD (2005)
IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma
LA Ehrlich et al.
BLOOD (2005)
Cancer and the microenvironment: Myeloma-osteoclast interactions as a model
S Yaccoby et al.
CANCER RESEARCH (2004)
The SCID-rab model:: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells
K Yata et al.
LEUKEMIA (2004)
A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow
RF Wynn et al.
BLOOD (2004)
The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma
E Tian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates
SM Devine et al.
BLOOD (2003)
Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity
S Yaccoby et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
分享论文
